# Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications

> **NCT00528671** · PHASE4 · TERMINATED · sponsor: **Heart and Diabetes Center North-Rhine Westfalia** · enrollment: 1571 (actual)

## Conditions studied

- Mechanical Heart Valve Recipients

## Interventions

- **DRUG:** phenprocoumon
- **DRUG:** phenprocoumon
- **DRUG:** phenprocoumon

## Key facts

- **NCT ID:** NCT00528671
- **Lead sponsor:** Heart and Diabetes Center North-Rhine Westfalia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 1571 (ACTUAL)
- **Last updated:** 2013-12-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00528671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00528671, "Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00528671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*